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The Reemergence of
Aedes aegypti in Arizona
To the Editor: Aedes aegypti, primarily an
urban, tropical mosquito, is a competent vector
of dengue and yellow fever viruses. In the early
1900s, Ae. aegypti was found in every country in
the Western Hemisphere except Canada. In the
United States, repeated attempts to eradicate it
have failed, and the mosquito is now well estab-
lished in the southern states, from Texas to
South Carolina, and more recently in Maryland
and New Jersey (1,2).
Although the arid landscape of southern Ari-
zona is an unlikely habitat for Ae. aegypti, these
mosquitoes were identified in the cities of
Tucson between 1931 and 1946 (3,4) and Yuma
in 1951 (5). Elsewhere in the western United
States, Ae. aegypti has been conspicuously
absent, except for periodic reports of populations
in New Mexico during this same period (3,6).
Beginning in 1969, the Arizona Department
of Health Services initiated an arbovirus surveil-
lance program involving state and local officials
in routine monthly mosquito sampling between
May and October of each year. Until 1994, no
Ae. aegypti specimens had been identified in
Arizona through routine surveillance, which
involved adult collection with CO2 and New
Jersey light traps and larval dipping surveys, or
through other mosquito research (7,8).
In August 1994, a University of Arizona
entomology professor reported finding several
Ae. aegypti in his Tucson backyard. Followup
surveys in September and October 1994 by state
and county health officials identified a number of
Ae. aegypti in that same neighborhood as well as
in central Tucson. During September 1995, addi-
tional specimens were collected in Nogales and
again in Tucson. The adult mosquitoes were col-
lected with CO2  traps in various locations in these
two cities. In Tucson, trapping from four of five
sites yielded 85 adult Ae. aegypti (8.5/trapnight).
In Nogales, trapping from two of four sites yielded
122 adults (12.2/trapnight). Trapping done earlier
in 1995 at these sites yielded no Ae. aegypti adults.
Between 1994 and 1995, Ae. aegypti were
trapped exclusively after the monsoon season (late
July to early September), when late summer pre-
cipitation allowed for sufficient breeding conditions
in backyards. However, in late March 1996, the
Arizona Department of Health Services responded
to a report of “ankle-biting” mosquitoes in central
Tucson. Subsequently, two adult Ae. aegypti were
trapped in the complainant’s home. Since then,
adult Ae. aegypti have been found in several new
areas in and around Tucson (0-10/trapnight). Adult
specimens have also been found for the first time
in the Arizona-Mexico border towns of Douglas
(<1/trapnight) and Naco (<1/trapnight; an addi-
tional 17 adults were collected by aspiration).
It is not certain whether Ae. aegypti mos-
quitoes were newly introduced in southern Ari-
zona, or if they have been present at low,
undetectable levels until favorable weather con-
ditions allowed the population to proliferate.
However, trapping data from the last three
decades suggest the former.
Oviposition trapping has been the method of
choice for Ae. aegypti surveillance (9). In Arizona
hay infusion-enhanced oviposition traps were used
(10). Because of the climate, initial attempts to
use oviposition traps for Ae. aegypti surveillance
were unsuccessful: the containers did not main-
tain enough water long enough for the hay infusion
to attract egg-laying. Future oviposition trapping
attempts will use variations on this trap, such as
more infusion medium and/or larger containers,
and will focus on careful trap placement. These
changes may yield a more appropriate Ae. aegypti
trap for use in the arid deserts of Arizona.
The establishment of populations of Ae. aegypti
in Arizona is of particular concern to the local
health services because of the presence of more
than 400 laboratory-confirmed cases of dengue
fever in the bordering Mexican state of Sonora in
1996 (R. Navarro Coronado, pers. comm.). While
no cases of endemic dengue have been reported in
Arizona, two imported cases were identified in
1994. Records show that between 1941 and 1946
nine cases of dengue fever were reported in
Arizona’s residents, eight of which were from the
Tucson and Nogales areas. No exposure or travel
history for those cases is available. Imported cases
of yellow fever were reported southeast of Tucson in
the late nineteenth century. The mere presence of
infected patients allowed for possible endemic
disease transmission, because of the simultaneous
presence of Ae. aegypti populations. If, or when,
new cases of dengue are identified in Arizona
residents, this same predicament will again
exist. Ae. aegypti surveillance throughout
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southern Arizona will be expanded in the coming
years, and surveillance will continue for new
dengue cases, imported or otherwise.
David M. Engelthaler, T. Michael Fink, Craig E.
Levy, and Mira J. Leslie
Arizona Department of Health Services, Phoenix,
Arizona, USA
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1991;7:52-5.Treatment of Exudative Pharyngitis
To the Editor: The dispatch by Izurieta et al.
(Emerg Infect Dis 1997;1:65-8) reporting exu-
dative pharyngitis possibly due to Corynebacterium
pseudodiphtheriticum was very interesting, espe-
cially with the resurgence of diphtheria in the
former Soviet Union. However, I was somewhat
surprised at the treatment received by the 4-
year-old patient whose case is reported. Erythromy-
cin is an effective antibiotic in diphtheria, but it is
secondary in importance to diphtheria antitoxin.
The presence of a thick grayish white adherent
pseudomembrane, adenopathy and cervical swel-
ling, and low grade fever should certainly
provoke a high index of suspicion of diphtheria,
especially in a child who has not received
pediatric immunization. The diagnosis of diph-
theria is primarily made presumptively on clinical
grounds and confirmed by the recovery of toxigenic
Corynebacterium diphtheriae by the laboratory.
Antitoxin treatment cannot wait for labora-
tory confirmation. Prompt administration of anti-
toxin is important because diphtheria toxin binds
rapidly and irreversibly to tissue sites. Delay in
initiating antitoxin treatment is associated with
increased incidence of myocarditis, paralysis,
and death. Also, it would have been good practice
to have placed this child in isolation until the
diagnosis was established by the laboratory. The
primary care physician in this case is indeed
fortunate that the patient did not have diph-
theria; the results could have been tragic.
Paul D. Ellner, Ph.D.
Professor Emeritus of Microbiology and Pathology,
Columbia University College of
Physicians and Surgeons
Reply to P.D. Ellner: We agree that diphtheria
antitoxin should be administered promptly on the
basis of a presumptive clinical diagnosis of
respiratory diphtheria. Because laboratory
confirma-tion may be delayed, the decision to
treat with antitoxin and the dose of antitoxin
must be based on the site and size of the
diphtheritic membrane, the degree of toxicity,
and the duration of illness (1,2).
Respiratory diphtheria is rare in the United
States. From 1980 to 1995, only 41 cases were
reported (zero to five cases in any given year) (3).
With this low incidence, the likelihood that a
patient with membranous pharyngitis has res-
piratory diphtheria is low. In addition, mem-
branous pharyngitis could be associated with
infections by other organisms such as streptococci,
Epstein Barr virus, Candida albicans, Borrelia
vincenti, Herpes simplex virus,  Arcanobacterium
hemoliticum, nontoxigenic Corynebacterium diph-
theriae, and Corynebacterium pseudodiphthe-
riticum as in the case we reported (4-10).
The diagnosis and clinical management of
exudative pharyngitis with a pseudomembrane in
a country where diphtheria is extremely rare
